Search
Close this search box.

How a Healthy Lifestyle Can Reduce Genetic Risk for Early Death by 62%

Living a healthy lifestyle can have a significant impact on reducing the risk of early death, even for individuals with...

Maintaining a healthy lifestyle is not only important for overall well-being, but new research suggests it may also play a...

The Food and Drug Administration (FDA) has recently approved an Investigational New Drug (IND) application for VYN202, a novel BD2-selective...

The Indian Pharmacopoeia Commission (IPC) and the Council of Scientific and Industrial Research-Institute of Microbial Technology (CSIR-IMTech) have recently announced...

A recent Phase 2 clinical trial of the lead NOX inhibitor candidate, setanaxib, has shown promising results in the treatment...

The Food and Drug Administration (FDA) has recently approved Myhibbin (mycophenolate mofetil) oral suspension for the prevention of organ rejection...

BioPharma Services, a leading contract research organization (CRO) specializing in early-phase clinical trials, has recently announced that they have received...

The Association of Clinical Research Professionals (ACRP) recently released a report titled “ACRP 2024: Workforce and Patient Engagement in Clinical...

A recent Phase 2 clinical trial has shown promising results for the use of Erleada in combination with androgen deprivation...

Mantle cell lymphoma (MCL) is a rare and aggressive form of non-Hodgkin lymphoma that typically affects older adults. While advancements...

Endometriosis is a common yet often misunderstood condition that affects millions of women worldwide. It occurs when tissue similar to...

A recent study has revealed promising results that suggest blood pressure medication may not only help lower blood pressure, but...

Amolyt Pharma, a biopharmaceutical company focused on developing innovative treatments for rare endocrine and metabolic diseases, recently announced that the...

The Environmental Protection Agency (EPA) has recently announced a significant allocation of $3 billion for the nationwide replacement of lead...

A new vaccine has shown promising results in protecting against a drug-resistant superbug in mice, according to a recent study...

Clinical research professionals play a crucial role in the development of new treatments and therapies for cancer patients. As part...

A recent study published in the journal Obesity has found that when it comes to weight loss, the number of...

When conducting a research study, selecting appropriate endpoints is crucial in order to accurately measure the outcomes of the study....

A promising new development has emerged in the field of cancer treatment, specifically for patients with B-cell lymphoma. The Phase...

The clinical trials industry plays a crucial role in the development of new medical treatments and therapies. In recent years,...

Summer camp can be a fun and exciting experience for children, but for those with allergies and asthma, it can...

Clinical trials are a crucial component of the medical research process, helping to determine the safety and effectiveness of new...

HealthTech, or healthcare technology, has revolutionized the way clinical trials are conducted in the medical field. With the integration of...

In the world of healthcare and clinical research, the use of technology has become increasingly important in collecting and analyzing...

Small cell lung cancer (SCLC) is a highly aggressive form of lung cancer that accounts for approximately 15% of all...

Relyvrio, a controversial drug used to treat ALS (amyotrophic lateral sclerosis), is being pulled off the market by its maker,...

Pharmacovigilance is a crucial aspect of the healthcare industry that focuses on monitoring and assessing the safety of pharmaceutical products....

A groundbreaking Phase 2a clinical trial of regenerative cell therapy for end-stage liver disease has recently begun, with the first...

Wet age-related macular degeneration (AMD) is a chronic eye disease that can cause severe vision loss in older adults. It...

A new study published in Drugs.com MedNews has shown promising results for a transdermal microporation system using zolmitriptan in the...

ACRP 2024 Highlights Workforce and Patient Engagement Challenges

The Association of Clinical Research Professionals (ACRP) recently released its 2024 report, highlighting the challenges faced by the clinical research industry in terms of workforce and patient engagement. The report sheds light on the critical issues that need to be addressed in order to improve the efficiency and effectiveness of clinical trials.

One of the key findings of the report is the shortage of qualified professionals in the clinical research field. The demand for skilled clinical research coordinators, data managers, and regulatory affairs specialists is on the rise, but there is a lack of trained professionals to fill these roles. This shortage is hindering the progress of clinical trials and slowing down the development of new treatments and therapies.

In addition to the workforce challenges, the report also highlights the importance of patient engagement in clinical research. Engaging patients in the clinical trial process is crucial for the success of a study, as it helps to ensure that the trial is conducted ethically and that the results are meaningful and relevant to patients. However, many clinical trials struggle to recruit and retain patients, leading to delays and increased costs.

To address these challenges, the ACRP recommends several strategies for improving workforce and patient engagement in clinical research. One of the key recommendations is to invest in training and education programs to develop a pipeline of skilled professionals in the clinical research field. By providing opportunities for professional development and career advancement, organizations can attract and retain top talent in the industry.

In terms of patient engagement, the ACRP suggests implementing patient-centered approaches to clinical trial design and recruitment. This includes involving patients in the study design process, providing clear and transparent information about the trial, and offering support and resources to help patients participate in the study.

Overall, the ACRP 2024 report highlights the importance of addressing workforce and patient engagement challenges in order to improve the efficiency and effectiveness of clinical trials. By investing in training programs, adopting patient-centered approaches, and fostering collaboration between stakeholders in the industry, we can overcome these challenges and drive innovation in clinical research.